146 related articles for article (PubMed ID: 26165612)
1. Male enhancement Nutraceuticals in the Middle East market: Claim, pharmaceutical quality and safety assessments.
ElAgouri G; ElAmrawy F; ElYazbi A; Eshra A; Nounou MI
Int J Pharm; 2015 Aug; 492(1-2):109-19. PubMed ID: 26165612
[TBL] [Abstract][Full Text] [Related]
2. Adulterated and Counterfeit Male Enhancement Nutraceuticals and Dietary Supplements Pose a Real Threat to the Management of Erectile Dysfunction: A Global Perspective.
ElAmrawy F; ElAgouri G; Elnoweam O; Aboelazayem S; Farouk E; Nounou MI
J Diet Suppl; 2016 Nov; 13(6):660-93. PubMed ID: 26913542
[TBL] [Abstract][Full Text] [Related]
3. Comparative Randomized Crossover Clinical Study for the Evaluation of Erectile Dysfunction Medications Via Novel Pentagon System.
Nounou MI; El Haddad G; El Amrawy F; El Gaddar O; El Yazbi A; Eshra A
Curr Drug Saf; 2018; 13(1):12-20. PubMed ID: 29359677
[TBL] [Abstract][Full Text] [Related]
4. The safety, efficacy and pharmaceutical quality of male enhancement nutraceuticals bought online: Truth versus claim.
Nounou MI; Eassa HA; Helal NA; AboulFotouh K; Mansoor I; Latz IK; Zheng C; Eassa HA; Mohamed D; Huynh DM; Wiss AR; Sweeney J; Oakes MT; Mikhail MM; Amine N; Kaur H; Echeverry N; Orzechowski K; Szollosi D
J Integr Med; 2021 May; 19(3):232-242. PubMed ID: 33736960
[TBL] [Abstract][Full Text] [Related]
5. Detection of 94 compounds related to sexual enhancement including sildenafil, tadalafil, vardenafil and their analogues in various formulations of dietary supplements and food samples using HPLC and LC-MS/MS.
Lee JH; Min AY; Park OR; Han JH; Yang YJ; Kim H; Baek SY
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2021 May; 38(5):769-781. PubMed ID: 33818311
[TBL] [Abstract][Full Text] [Related]
6. Erectile Dysfunction Drugs Changed the Protein Expressions and Activities of Drug-Metabolising Enzymes in the Liver of Male Rats.
Sheweita SA; Wally M; Hassan M
Oxid Med Cell Longev; 2016; 2016():4970906. PubMed ID: 27800121
[TBL] [Abstract][Full Text] [Related]
7. Screening and Determination of Synthetic PDE-5 Inhibitors in Adulterated Sexual Enhancement Supplements.
Jairoun AA; Al-Hemyari SS; Shahwan M; Zyoud SH; Ibrahim B; Zyoud SH
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235271
[TBL] [Abstract][Full Text] [Related]
8. Identification of Erectile Dysfunction Drugs in Dietary Supplements by Liquid Chromatography Ion Trap Mass Spectrometry.
Li C; Xu D; Moezzi B
J Diet Suppl; 2021; 18(3):261-277. PubMed ID: 32351143
[TBL] [Abstract][Full Text] [Related]
9. Reliable screening and classification of phosphodiesterase type 5 inhibitors in dietary supplements using gas chromatography / mass spectrometry combined with specific common ions.
Lee W; Kim HJ; Lee ME; Kim BH; Park S; Lee JH; Lee YM; Oh HB; Hong J
J Chromatogr A; 2020 Jul; 1623():461210. PubMed ID: 32505294
[TBL] [Abstract][Full Text] [Related]
10. Screening of Phosphodiesterase-5 Inhibitors and Their Analogs in Dietary Supplements by Liquid Chromatography-Hybrid Ion Trap-Time of Flight Mass Spectrometry.
Kim U; Cho HD; Kang MH; Suh JH; Eom HY; Kim J; Seo S; Kim G; Koo HR; Ha N; Song UT; Han SB
Molecules; 2020 Jun; 25(12):. PubMed ID: 32545673
[TBL] [Abstract][Full Text] [Related]
11. Detection of a tadalafil analogue as an adulterant in a dietary supplement for erectile dysfunction.
Ulloa J; Sambrotta L; Redko F; Mazza ON; Garrido G; Becher EF; Muschietti L
J Sex Med; 2015 Jan; 12(1):152-7. PubMed ID: 25402198
[TBL] [Abstract][Full Text] [Related]
12. Phosphodiesterase-5 inhibitors and their analogues as adulterants of herbal and food products: analysis of the Malaysian market, 2014-16.
Bujang NB; Chee CF; Heh CH; Rahman NA; Buckle MJC
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2017 Jul; 34(7):1101-1109. PubMed ID: 28580889
[TBL] [Abstract][Full Text] [Related]
13. Analytical methods for the detection and characterization of unapproved phosphodiesterase type 5 inhibitors (PDE-5i) used in adulteration of dietary supplements- a review.
Kee CL; Ge X; Low MY; Gilard V; Malet-Martino M
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2023 Dec; 40(12):1495-1530. PubMed ID: 38011602
[TBL] [Abstract][Full Text] [Related]
14. Over-the-Counter Herbal Weight Loss Supplements in Egypt: Label Claim, Microbiological and Pharmaceutical Quality, and Safety Assessments.
Ahmed N; Nounou MI; Abouelfetouh A; El-Kamel A
Med Princ Pract; 2019; 28(2):167-177. PubMed ID: 30517949
[TBL] [Abstract][Full Text] [Related]
15. "One-shot" analysis of PDE-5 inhibitors and analogues in counterfeit herbal natural products using an LC-DAD-QTOF system.
Bortolini C; Pivato A; Bogialli S; Pastore P
Anal Bioanal Chem; 2015 Aug; 407(20):6207-16. PubMed ID: 26072210
[TBL] [Abstract][Full Text] [Related]
16. Detection of 94 PDE-5is and Their Analogs Including N-Desmethylthiosildenafil in Various Formulations of Dietary Supplements and Food Samples Using HPLC and LC-Q-TOF/MS.
Lee JH; Park OR; Yang YJ; Han JH; Jung EJ; Kim NS; Baek SY
J Chromatogr Sci; 2022 Dec; 60(10):953-962. PubMed ID: 35535451
[TBL] [Abstract][Full Text] [Related]
17. Qualitative and quantitative analysis of PDE-5 inhibitors in counterfeit medicines and dietary supplements by HPLC-UV using sildenafil as a sole reference.
Fejős I; Neumajer G; Béni S; Jankovics P
J Pharm Biomed Anal; 2014 Sep; 98():327-33. PubMed ID: 24996004
[TBL] [Abstract][Full Text] [Related]
18. 10-Year analysis of adverse event reports to the Food and Drug Administration for phosphodiesterase type-5 inhibitors.
Lowe G; Costabile RA
J Sex Med; 2012 Jan; 9(1):265-70. PubMed ID: 22023666
[TBL] [Abstract][Full Text] [Related]
19. Screening of Indian aphrodisiac ayurvedic/herbal healthcare products for adulteration with sildenafil, tadalafil and/or vardenafil using LC/PDA and extracted ion LC-MS/TOF.
Savaliya AA; Shah RP; Prasad B; Singh S
J Pharm Biomed Anal; 2010 Jul; 52(3):406-9. PubMed ID: 19540696
[TBL] [Abstract][Full Text] [Related]
20. The POWER saga from 2007 to 2022: An example of a sexual enhancement dietary supplement tainted by different adulterants and still on the market.
Balayssac S; Danoun S; Gilard V; Martino R; Malet-Martino M
J Pharm Biomed Anal; 2023 Apr; 227():115283. PubMed ID: 36780864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
